Animal studies have revealed no teratogenic, embryotoxic or fetotoxic effects. There are no controlled data in human pregnancy. AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations.
These effects may be reversible. Accompanying texts should be consulted for further details. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Use is not recommended. AU TGA pregnancy category: C US FDA pregnancy category: B Comments: -The use of effective contraception is advised during treatment and for at least 5 months after discontinuation.
Source: Adalimumab Use During Pregnancy | Drugs.com
Tags: Dermatology HUMIRA Pregnancy Treatment
 Use During Pregnancy){kind=link}